Search
Learn about a potential new strategy for treating people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) that targets a protein on cancer stem cells.
Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.
A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.
An effective treatment may have emerged for some people with uveal melanoma, a rare cancer that forms in the eye.
Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia, published in Developmental Cell in 2016.
The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC).
Meet Dr. Monique James, who is part of MSK’s Department of Psychiatry and Behavioral Sciences. Her journey with MSK started 18 years ago before she even started medical school.
Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
A rare form of stomach cancer caused by an inherited gene mutation can be avoided by having the stomach removed — and many people can adjust to life afterward.
Craig B. Thompson, Lisa DeAngelis, and Joan Massagué write that as we mark the 50th year of the War on Cancer and look to the future, our mission at Memorial Sloan Kettering is nothing less than conquering the most urgent challenge: preventing cancer’s spread.